Sale!

OncoPro Comprehensive Cancer Panel 161 Genes Test

Original price was: R18,200.Current price is: R16,400.

-10%

Facing cancer concerns can be overwhelming, but knowledge is your greatest ally. The OncoPro Comprehensive Cancer Panel 161 Genes Test provides the clarity you need with advanced genetic analysis that examines 161 cancer-related genes. For ZAR 16,400, this comprehensive test offers personalised insights into your cancer risk profile, helping you and your healthcare team make informed decisions about prevention and treatment strategies. Using Next Generation Sequencing technology with 99.9% accuracy, this test analyses 86 hotspot genes, 47 full-length genes, copy number variations in 43 genes, and fusions in 48 genes. Whether you’re concerned about family history, experiencing unexplained symptoms, or seeking proactive health management, this test delivers the comprehensive information needed for personalised cancer care. Available nationwide across South Africa including Johannesburg, Cape Town, and Durban, with results in just 35 working days.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

OncoPro Cancer Panel 161 Genes Test | ZAR 16
OncoPro Comprehensive Cancer Panel 161 Genes Test
R18,200 Original price was: R18,200.R16,400Current price is: R16,400.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Take Control of Your Cancer Journey with Advanced Genetic Insights

When cancer concerns arise, the uncertainty can feel overwhelming. We understand that waiting for answers is one of the most challenging parts of any health journey. The OncoPro Comprehensive Cancer Panel 161 Genes Test provides the clarity and confidence you deserve, offering personalised genetic insights that can transform your approach to cancer prevention and treatment.

What This Test Reveals About Your Cancer Risk

This comprehensive genetic analysis examines 161 cancer-related genes using advanced Next Generation Sequencing technology with 99.9% accuracy. Unlike standard tests, the OncoPro panel provides a complete picture of your genetic cancer risk by analysing:

  • 86 Hotspot Genes: Identifies specific mutations known to drive cancer development
  • 47 Full-Length Genes: Examines entire gene sequences for comprehensive risk assessment
  • Copy Number Variations in 43 Genes: Detects gene duplications or deletions that increase cancer susceptibility
  • Fusions in 48 Genes: Identifies abnormal gene combinations that can trigger cancer growth

Who Should Consider This Comprehensive Cancer Panel?

This test provides valuable insights for South Africans facing various cancer concerns:

  • Individuals with Family Cancer History: If multiple relatives have had cancer, especially at young ages
  • People with Unexplained Symptoms: Persistent fatigue, unexplained weight loss, or unusual lumps
  • Cancer Survivors: Monitoring for recurrence or assessing risk for additional cancers
  • Those Seeking Proactive Health Management: Taking control of your health before symptoms appear
  • Patients with Previous Abnormal Results: Needing more detailed genetic analysis

Why This Matters for Your Health Journey

Early detection and personalised insights can significantly impact your cancer journey:

  • Personalised Prevention Strategies: Tailor screening and lifestyle choices based on your genetic profile
  • Informed Treatment Decisions: Guide your healthcare team in selecting the most effective therapies
  • Family Health Awareness: Provide valuable information for relatives about inherited cancer risks
  • Peace of Mind: Reduce uncertainty with comprehensive genetic information
  • Proactive Health Management: Take control of your health with evidence-based insights

Understanding Your Results with Compassionate Guidance

We know that waiting for genetic test results can be anxiety-provoking. Our comprehensive report includes:

  • Clear, Understandable Language: Results explained in terms you can understand
  • Personalised Risk Assessment: Specific insights about your cancer susceptibility
  • Actionable Recommendations: Practical next steps for prevention and monitoring
  • Genetic Counselling Support: Professional guidance to help interpret your results
  • Healthcare Team Coordination: Seamless communication with your doctors

Remember: Knowledge empowers you to make informed decisions about your health journey.

Invest in Your Health with Transparent Pricing

Service Regular Price Special Price Savings
OncoPro Comprehensive Cancer Panel 161 Genes ZAR 18,200 ZAR 16,400 ZAR 1,800

Turnaround Time: Sample collection daily by 11 am | Results in 35 working days

Sample Requirements: Formalin fixed paraffin embedded (FFPE) tissue block with at least 10% tumor tissue

Why South Africans Trust Oracle Genomics

  • Nationwide Coverage: Available across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
  • Medical Expertise: Developed and interpreted by leading oncologists and genetic specialists
  • Advanced Technology: Next Generation Sequencing with 99.9% accuracy
  • Patient-Centred Care: Compassionate support throughout your testing journey
  • Proven Reliability: Trusted by healthcare professionals nationwide

Take the First Step Toward Clarity and Confidence

Don’t let uncertainty control your health journey. With the OncoPro Comprehensive Cancer Panel, you gain the genetic insights needed to make empowered decisions about your cancer care.

Multiple Ways to Book Your Test:

  • Online Booking: Secure, confidential booking available 24/7
  • Telephone Consultation: Speak with our genetic counselling team
  • Healthcare Provider Referral: Coordinate through your doctor
  • Walk-in Appointments: Available at our nationwide centres

Limited Time Special: Save ZAR 1,800 on this comprehensive cancer panel. Take action today for peace of mind tomorrow.

“Early genetic insights can transform cancer outcomes. Every day matters when it comes to proactive health management.” – Oracle Genomics Oncology Team